ERBB2 and breast carcinoma: In another study, Zhu et al. [30] reported an electrochemical stripping voltammetry biosensor for the detection of both human epidermal growth factor receptor 2 (HER2) protein and SK-BR-3 breast cancer cells, which takes advantage of hydrazine and aptamer-conjugated gold nanoparticles.